Tehrani Ali's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jul 16, 2021
- Accession no.
- 0000899243-21-028760
- Filed
- Jul 16, 2021
- Trade date
- Jul 15-16, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.62M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tehrani AliCIK 0001761853 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Common Shares | MOption exerciseAcquired | +3,800 | $4.27F2 | +$16,226 | 264,125 | Direct | |
| Jul 15, 2021 | Common Shares | SSaleDisposed | −3,800 | $36.00F3 | −$136,800 | 260,325 | Direct | |
| Jul 16, 2021 | Common Shares | MOption exerciseAcquired | +41,191 | $4.26F4 | +$175,473.66 | 301,516 | Direct | |
| Jul 16, 2021 | Common Shares | SSaleDisposed | −41,191 | $36.00F3 | −$1,482,876 | 260,325 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 | Common Shares | MOption exerciseDisposed | −3,800 | $0.00 | $0 | 41,191 | Direct | |
| Jul 16, 2021 | Common Shares | MOption exerciseDisposed | −41,191 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2713 using the Bank of Canada exchange rate for July 15, 2021 (CAD1.00 = $0.7954).
Referenced by the price of 1 transaction in Table I.
- F3
All shares were sold at $36.00 per share.
Referenced by the price of 2 transactions in Table I.
- F4
The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.2643 using the Bank of Canada exchange rate for July 16, 2021 (CAD1.00 = $0.7941).
Referenced by the price of 1 transaction in Table I.